- RFP 2026-017: Mass drug administration with Artemether Lumefantrine in Cauca, Colombia
-
PATH, through the REACH Malaria project, is soliciting proposals from qualified institutions to support the preparation, implementation, and evaluation of a malaria chemoprevention campaign in the municipality of Guapi, Cauca, Colombia.
The assignment includes implementation of a dual strategy: (i) Mass Drug Administration (MDA) in prioritized rural riverine communities, delivered through supervised, door‑to‑door administration over two rounds, and (ii) Reactive Drug Administration (RDA) in urban and peri‑urban areas, consisting of supervised treatment of cohabitants of confirmed cases.
The selected contractor will be responsible for operational planning, community engagement, training and supervision of field teams, logistics and procurement of non‑drug materials, pharmacovigilance and reporting, and a post‑campaign survey to assess coverage and implementation performance. The work requires demonstrated capacity to implement large‑scale, community‑based public health campaigns in rural and urban settings, in close coordination with national and local health authorities.
RFP schedule
March 30, 2026: Request for proposal (RFP) released
April 3, 2026: Confirmation of interest in submitting a proposal and deadline to submit queries/ clarifications from potential bidders
April 8, 2026: PATH response to all queries/clarifications from potential bidders
April 21, 2026: Deadline for submission of proposal in response to the RFP
April 30, 2026: Outcome communication (including clarifications and references verifications)
Documents
Our principles
PATH subscribes to principles of simplicity and economy in procurement operations. We comply with US government procurement integrity regulations, anti-terrorism regulations, and Equal Employment Opportunity legislation.